COMMUNIQUÉS West-GlobeNewswire

-
ONWARD® Medical Reports Full Year 2023 Financial and Operating Results and Shares 2024 Highlights Year-to-Date
25/04/2024 -
Santhera Announces Preliminary Unaudited 2023 Annual Results and Provides Corporate Update Ahead of Full Report Publication in May
25/04/2024 -
Junshi Biosciences Announces NDA Acceptance in Hong Kong for Toripalimab
25/04/2024 -
Merus annonce les résumés acceptés pour présentation à la réunion annuelle 2024 de l’ASCO
25/04/2024 -
Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024
24/04/2024 -
Vistin Pharma ASA: Annual Report 2023
24/04/2024 -
Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K
24/04/2024 -
Amedisys Reports First Quarter 2024 Financial Results
24/04/2024 -
NKGen Biotech Announces Upcoming Publication at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
24/04/2024 -
NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Results
24/04/2024 -
NANOBIOTIX FAIT LE POINT SUR SES ACTIVITÉS ET PUBLIE SES RÉSULTATS FINANCIERS POUR L’ANNÉE 2023
24/04/2024 -
BioAtla Announces Upcoming Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
24/04/2024 -
Hapbee Announces Closing of Private Placement
24/04/2024 -
Arvinas Appoints Randy Teel, Ph.D., as Chief Business Officer
24/04/2024 -
IO Biotech Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
24/04/2024 -
STERIS to Host a Conference Call for Fiscal 2024 Fourth Quarter and Full Year Financial Results on May 9, 2024
24/04/2024 -
Entourage Health to Report Fiscal Year 2023 Financial Results
24/04/2024 -
Spectral AI Schedules 2024 First Quarter Financial Results and Conference Call
24/04/2024 -
Supernus Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024
24/04/2024
Pages